To: From: Sent: Subject:
Jackson, Ryan[jackson.ryan@epa.gov] hutchinsont@gtlaw.com Fri 8/25/2017 1:35:31 PM EPA regulation of mosquito-related products
Ryan--
I hope you are well and have a little time to catch up this month. I know it has been a hectic few months.
I was hoping that you could provide a little information about a jurisdictional issue involving EPA and FDA. I represent Intrexon, which has a subsidiary (Oxitec) that produces a genetically modified mosquito that may become a valuable resource for preventing the spread of the Zika virus and other diseases transmitted by the same type of mosquito (aedes aegypti). Back in January, EPA and FDA issued draft guidance for industry on the regulation of mosquito-related products and took public comments. It is my understanding that this guidance is very close to being finalized, and may have already cleared 0MB review. I was wondering if you could share any information about when this guidance is expected to be finalized and take effect.
As always, thanks for your assistance.
Tim
The Honorable Tim Hutchinson Senior Director (US House 93-97; US Sen. 97-03) Greenberg Traurig, LLP | 2101 L Street N.W. | Washington, D.C. 20037 Tel 202.530.8512
hutchinsont@qtlaw.com | www.qtlaw.com
17cv1906 Sierra Club v. EPA
ED_001523_00000812-00001
eenbergTraung
If you are not an intended recipient of confidential and privileged information in this email, please delete it, notify us immediately at postmaster@gtlaw.com, and do not use or disseminate such information.
17cv1906 Sierra Club v. EPA
ED_O01523_00000812-00002